|
[1]
|
中国过敏性鼻炎研究协作组. 过敏性鼻炎皮下免疫治疗专家共识2015 [J]. 中国耳鼻咽喉头颈外科, 2015(8): 379-404.
|
|
[2]
|
Canonica, G.W., Bousquet, J., Casale, T., et al. (2009) Sub-Lingual Immunotherapy: World Allergy Or-ganization Position Paper 2009. Allergy, 64, 1-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Canonica, G.W. (2011) History of the World Allergy Organization: Innovation in Continuity 2008-2009. World Allergy Organiza-tion Journal, 4, 188-192. [Google Scholar] [CrossRef]
|
|
[4]
|
Alvarez-Cuesta, E., Bousquet, J., Canonica, G.W., et al. (2006) Standards for Practical Allergen-Specific Immunotherapy. Allergy, 61, 1-3. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
中国过敏性鼻炎研究协作组. 过敏性鼻炎皮下免疫治疗的安全性[J]. 中国耳鼻咽喉头颈外科, 2017, 24(1): 1-14.
|
|
[6]
|
尹佳. 北京协和医院变应原制剂应用指南[M]. 北京: 中国协和医科大学出版社, 2014.
|
|
[7]
|
Yukselen, A. (2016) Allergen-Specific Immunotherapy in Pediatric Al-lergic Asthma. Asia Pacific Allergy, 6, 139-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
李勇. 变应性鼻炎免疫治疗共识及相关进展[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 15-21.
|
|
[9]
|
Nacaroglu, H.T., Erdem, S.B., Sumer, O., et al. (2016) Local and Systemic Reactions to Subcutaneous Allergen Immunotherapy. Annals of Allergy, Asthma & Immunology, 116, 349-353. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
冯仙, 刘琢扶, 顾泓, 等. 变应性鼻炎患者皮下特异性免疫治疗的全身不良反应情况分析[J]. 中国眼耳鼻喉科杂志, 2019, 19(4): 262-266.
|
|
[11]
|
向莉, 申昆玲, 张鸿燕, 等. 哮喘患儿对标准化尘螨特异性免疫治疗剂量递增阶段的耐受性[J]. 中国实用儿科杂志, 2006(12): 924-926.
|
|
[12]
|
Nettis, E., Giordano, D., Pannofino, A., et al. (2002) Safety of Inhalant Allergen Immunotherapy with Mass Units- Standardized Extracts. Clinical & Experimental Allergy, 32, 1745-1749. [Google Scholar] [CrossRef] [PubMed]
|